首页> 外文OA文献 >Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry

【2h】

Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry

机译：在美国Corrona注册表中，类风湿关节炎患者先前接受过抗肿瘤坏死因子治疗后，利妥昔单抗与随后的抗肿瘤坏死因子治疗的比较有效性和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Leslie R. Harrold; George W. Reed; Robert Magner; Ashwini Shewade; Ani John; Jeffrey D. Greenberg; Joel M. Kremer;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry [J] . Leslie R Harrold, George W Reed, Robert Magner, Arthritis research & therapy. . 2015,第1期

机译：在美国Corrona注册表中，类风湿关节炎患者先前接受过抗肿瘤坏死因子治疗后，利妥昔单抗与后续抗肿瘤坏死因子治疗的有效性和安全性比较
2. Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry [J] . Leslie R. Harrold, George W. Reed, Robert Magner, Arthritis research & therapy. . 2015,第Mara期

机译：Rituximab与随后的抗肿瘤坏死因子治疗的对比效果和安全性关节炎患者，以前暴露于美国科罗拉州注册表的抗肿瘤坏死因子疗法
3. Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry [J] . Leslie R. Harrold, Heather J. Litman, Sean E. Connolly, Rheumatology and Therapy . 2019,第2期

机译：在美国Corrona Registry中抗CCP阳性的类风湿性关节炎患者中Abatacept与肿瘤坏死因子抑制剂的比较有效性
4. A HDX/MS analysis of the interaction between human tumor necrosis factor-alpha (TNFα) and anti-TNFαagents [C] . Shiori Nakazawa, Noritaka Hashii, Nana Kawasaki American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：HDX / MS分析人肿瘤坏死因子-α（TNFα）和抗TNFα之间的相互作用
5. Predictors of Infection in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents [D] . Liu, Tasia 2017

机译：类风湿关节炎患者使用抗肿瘤坏死因子药物的感染预测因子
6. Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry [O] . Leslie R. Harrold, George W. Reed, Robert Magner, 2015

机译：在美国Corrona注册表中类风湿性关节炎患者在事先接受过抗肿瘤坏死因子治疗的情况下利妥昔单抗与后续抗肿瘤坏死因子治疗的有效性和安全性比较
7. Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry [O] . Leslie R. Harrold, Heather J. Litman, Sean E. Connolly, 2019

机译：类风湿性关节炎患者AbataCept与肿瘤坏死因子抑制剂的对比有效性，其在美国科技RODORA注册表中抗CCP阳性

相关主题

Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry

著录项

相似文献

相关主题

期刊订阅